Oral tranexamic acid beneficial for melasma in vitiligo patients: study
Oral Tranexamic Acid (OTA) is feasible and a useful treatment modality treating melasma in vitiligo patients, suggests a study published in the Dermatologic Therapy.
Melasma and vitiligo are both very common pigmentary disorders and their treatment is quite challenging. Clinically vitiligo is characterised by well-circumscribed, depigmented macules and patches secondary to selective destruction of melanocytes in the skin and mucous membrane, whereas melasma is characterized by symmetrical hyperpigmented macules on the face.Oral tranexamic acid (TA) is effective for refractory melasma; however, the feasibility of Oral tranexamic acid (TA) in vitiligo patients with melasma has not been previously studied. A group of researchers from Chang Gung University, Taoyuan, Taiwan conducted a study to evaluate the treatment outcomes and adverse effects of Oral tranexamic acid (TA) in vitiligo patients suffering from melasma.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.